GMED vs. JNJ

In the year-to-date period, GMED achieves a -12.28% return, which is significantly lower than JNJ's 14.11% return. Over the past 10 years, GMED has outperformed JNJ with an annualized return of 11.16%, while JNJ has yielded a comparatively lower 8.12% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GMED Sharpe Ratio is 1.24, which is higher than the JNJ Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of GMED and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GMED has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 3.03%.

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for GMED and JNJ. For additional features, visit the drawdowns tool.

Globus Medical, Inc. (GMED) has a higher volatility of 9.37% compared to Johnson & Johnson (JNJ) at 3.79%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Globus Medical, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.